Boston Scientific shares slip 4.67% and underperform competitors
Updated
Updated · MarketWatch · May 8
Boston Scientific shares slip 4.67% and underperform competitors
12 articles · Updated · MarketWatch · May 8
The stock closed at $53.93 on Friday as the S&P 500 rose 0.84% to 7,398.93 and the Dow added 0.02% to 49,609.16.
The decline ended a two-day winning streak, while Abbott fell 3.09%, Medtronic 2.32% and Stryker 2.98%, leaving Boston Scientific the weakest among the peers cited.
Boston Scientific finished 50.75% below its 52-week high of $109.50 reached on 9 September, and trading volume of 20.4 million topped its 50-day average of 16.5 million.
With record sales but a stock down 50%, is Boston Scientific a historic bargain or a dangerous value trap?
Why is Wall Street punishing Boston Scientific despite the company posting its strongest-ever financial results?